Breastmilk Composition and Microbial Profile in the Growth and Development of Healthy Term-born Infants
NCT ID: NCT06970535
Last Updated: 2025-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2021-09-15
2026-01-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN)
NCT06691932
Maternal Obesity, Breast Milk Composition, and Infant Growth
NCT03301753
Impact of Breast Milk miRNAs on the Infant Gut Microbiota
NCT06651216
Facilitation and Barriers to Breastfeeding in the NICU
NCT00527956
Responsive Feeding of Infants With Expressed Milk
NCT04041505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
STUDY OBJECTIVES:
1. To evaluate the influence of maternal metabolic status, on breastmilk composition (energy, macronutrient and micronutrient content and microbial profile) at three months post-partum.
* Maternal metabolic status will be characterized by: maternal obesity (measured), diabetes, hypertension and gestational weight gain (self-reported).
2. To assess the associations between breastmilk composition and obesity, asthma and allergy in the children longitudinally to five years of age.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child is between two and four months of age at recruitment.
* The child is healthy.
* Child is fed exclusively mother's milk and has not received any infant formula, cow's milk, juice, tea, or solids in the two weeks prior to recruitment.
* The mother of the child is present at the time of recruitment.
Exclusion Criteria
* The child has been diagnosed with a health condition affecting growth (e.g. failure to thrive, cystic fibrosis).
* The child has been diagnosed with any acute or chronic conditions.
* The family of the child is unable to communicate in English.
2 Months
4 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health
OTHER
University of Toronto
OTHER
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deborah O'Connor
Senior Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deborah L O'Connor, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Catherine Birken, MD,MSc,FRCPC
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Jonathon Maguire, MD,MSc,FRCPC
Role: PRINCIPAL_INVESTIGATOR
Unity Health Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unity Health Toronto
Toronto, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1000067542
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.